Bozor bahosi: Actuate Therapeutics Inc. (ACTU)

Actuate Therapeutics, Inc (ACTU) grafik logotipi

Actuate Therapeutics, Inc. (ACTU) aksiyalarining 0.01 vaqtida qayd etilgan bozor tendentsiyasi, ortiqcha infratuzilma xarajatlarini bartaraf etuvchi ishlab chiqarishni autsorsing qilish modeli bilan boshqarilmoqda. O'sish miya va oshqozon osti bezi o'smalaridagi qarshilikka yo'naltirilgan eksklyuziv patentlar bilan qo'llab-quvvatlanmoqda. Kelajakka nazar tashlab, Actuate Therapeutics, Inc. (ACTU) onkologiya sektoridagi o'z mavqeyini kengaytirish uchun II bosqich sinovlari natijalaridan foydalangan holda elraglusib preparatini global miqyosda joriy qilishni rejalashtirmoqda.

ACTU (actuatetherapeutics.com) Bozor kapitallashuvi tarixi 14.08.2024dan 16.11.2026gacha

actuatetherapeutics.com (ACTU) kompaniyasi koʻrsatkichlari kesimi va tahlili

- joriy narx va aksiyalarning prognoz qilingan qiymati:
- kompaniyaning birjadagi kapitallashuv ko'rsatkichlari:
Kompaniyaning fundamental baholanishi:Actuate Therapeutics Inc ACTU
Actuate Therapeutics, Inc. tovar namunasi

Bozor kapitalizatsiyasi barcha aksiyalarning qiymatini umumlashtirib, korxonaning umumiy aktivlariga oid investorlarning joriy konsensusini aks ettiradi. Ushbu ko'rsatkich institutsional talabni bozor narxlari prizmasi orqali o'lchaydi. Emitentning bozor qiymatini tahlil qilish shuni ko'rsatadiki, Actuate Therapeutics, Inc. (ACTU) baholanishi GSK-3 inhibitorining istiqbollariga bog'liq. Ushbu metrikadagi tebranishlar dori vositasining klinik sinov risklarining qayta baholanishidan dalolat beradi. Ushbu ko'rsatkichning tendentsiyasi kompaniyaning biotexnologiya sektori doirasidagi investitsiyaviy jozibadorligini belgilaydi.

Actuate Therapeutics, Inc. (ACTU) raqobatchilari

Bozor qiymati BeiGene Ltd ONC|Bozor kapitallashuvi Halozyme Corp HALO|RVMD - Bozor qiymati|Bozor bahosi AAPG|CG Oncology Corp (CGON) - Bozor qiymati|Bozor kapitallashuvi URGN|BCAX (Bicara Corp) - Bozor kapitallashuvi|Bozor bahosi Personalis Corp (PSNL)|Bozor kapitallashuvi ERAS|Bozor kapitallashuvi delcath.com (DCTH)|Bozor qiymati YmAbs YMAB|AURA: Bozor kapitallashuvi|Candel Therapeutics, Inc. - Bozor kapitallashuvi|Accuray Inc. (ARAY) - Bozor bahosi|SELLAS Life Sciences Group Inc. (SLS) - Bozor qiymati|Bozor qiymati citiusonc.com (CTOR)|Bozor qiymati tuhurabio.com|TARA: Bozor qiymati|Bozor bahosi FATE (Fate Therapeutics Corp)|WHWK (Aadi Bioscience) - Bozor qiymati|Bozor kapitallashuvi TCRX (TScan Therapeutics)|CSBR - Bozor bahosi|XBIT: Bozor bahosi|Bozor qiymati CVM (cel-sci.com)|OS Therapies Inc (OSTX) - Bozor qiymati|Radiopharm Theranostics - Bozor qiymati|ARTV (Artiva Biotherapeutics Inc.) - Bozor kapitallashuvi|Bozor kapitallashuvi Adlai Nortye Ltd.|Bozor bahosi VERU (Veru)|Bozor qiymati TPST|Bozor qiymati Xilio XLO|Renovaro Inc. (RENB) - Bozor qiymati|MURA - Bozor qiymati|Bozor kapitallashuvi Kairos Pharma KAPA|OKUR (OnKure Therapeutics) - Bozor bahosi|Bozor qiymati CytoMed (GDTC)|Bozor qiymati Curis|Bozor qiymati APLM|Bozor qiymati tharimmune.com (THAR)|Bozor bahosi Advanced Biomed ADVB|Genprex, Inc - Bozor bahosi|Bozor qiymati CLDI|sunshinebiopharma.com - Bozor kapitallashuvi|Bozor qiymati XBIO (xeneticbio.com)|SLRX (Salarius Pharmaceuticals) - Bozor bahosi|PPBT - Bozor kapitallashuvi|Bozor qiymati American Oncology Network Inc|BGNE (BeiGene) - Bozor qiymati|Bozor bahosi CKPT (Checkpoint Therapeutics, Inc)|ELEV - Bozor qiymati|Bozor kapitallashuvi ICAD (iCAD Inc.)|Ikena (IKNA) - Bozor qiymati|NTBL: Bozor bahosi|VIRX - Bozor kapitallashuvi|MorphoSys Corp (MOR) - Bozor qiymati|Bozor bahosi NAYA Bio|Bozor qiymati Ascentage Pharma Group